Home / ANKRD9 Knockout Cell Lines

ANKRD9 Knockout Cell Lines

Gene: ANKRD9

Official Full Name: ankyrin repeat domain 9provided by HGNC

Gene Summary: Enables ubiquitin-like ligase-substrate adaptor activity. Involved in intracellular copper ion homeostasis; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein ubiquitination. Located in cytoplasmic vesicle and cytosol. Part of Cul5-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO28926 ANKRD9 Knockout cell line (HeLa) Human ANKRD9 1:3~1:6 Negative Online Inquiry
KO28927 ANKRD9 Knockout cell line (HCT 116) Human ANKRD9 1:2~1:4 Negative Online Inquiry
KO28928 ANKRD9 Knockout cell line (HEK293) Human ANKRD9 1:3~1:6 Negative Online Inquiry
KO28929 ANKRD9 Knockout cell line (A549) Human ANKRD9 1:3~1:4 Negative Online Inquiry

Background

ANKRD9 Gene Knockout Cell Lines are specialized cellular models engineered to completely disable the expression of the ANKRD9 gene. This gene, known to be involved in protein interactions and cellular signaling pathways, plays a crucial role in regulating various biological processes, including those associated with cancer and immune response. By employing CRISPR-Cas9 technology, these cell lines enable researchers to investigate the functional consequences of ANKRD9 gene loss, leading to deeper insights into its biological roles and potential implications in disease states.

The primary function of ANKRD9 Gene Knockout Cell Lines lies in their ability to facilitate focused studies on gene function, cellular behavior, and the molecular underpinnings of signaling pathways. Researchers can manipulate these cell lines to assess changes in proliferation, apoptosis, and metabolic activities, offering a robust platform for pharmacological testing and mechanistic studies. Through systematic analysis, these models support investigations into how perturbations of the ANKRD9 gene can contribute to the pathogenesis of various conditions, including cancers and autoimmune diseases.

From a scientific standpoint, the availability of knockout cell lines represents a pivotal advancement in genomic research and therapeutic development. Their utility extends into clinical research settings, where understanding gene function can inform targeted therapies and biomarker identification. ANKRD9 Gene Knockout Cell Lines offer unique advantages over traditional models, such as primary cells or non-targeted knockout approaches, by providing consistent and reproducible results, which is critical for obtaining reliable data.

For researchers and clinicians focused on gene function and therapeutic discovery, these cell lines are invaluable. They not only streamline experimental workflows, but also expedite the translation of findings into practical applications. By using our ANKRD9 Gene Knockout Cell Lines, users can enhance their research capabilities and contribute to the advancement of precision medicine.

Our company is committed to advancing life sciences by providing high-quality research tools backed by extensive expertise in genetic engineering and cell line development. With a focus on innovation and reliability, we empower the scientific community to explore new frontiers in biological research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.